News | August 25, 2010

Mayo Clinic Doctors Plant the Seeds of Success in Cancer Surgery

August 25, 2010 - A new technique that combines advanced radiologic imaging with precise tumor localization to remove a cancer in its entirety and with minimal disturbance to surrounding organs is available.

As reported in the latest issue of the Journal of Surgical Radiology, surgeons and radiologists at the Mayo Clinic have collaborated on an approach that uses tiny radioactive seeds implanted at the time of diagnosis. Surgeons can then use a handheld radiation detector (gamma probe) to precisely locate these seeds at the time of surgery and thereby remove the cancer safely and effectively, virtually without damaging tissues and organs near the affected area.

“RSL (radioactive seed localization) is a safe, accurate, and effective technique,” according to Dr. James Jakub, the senior author of the study and a surgeon at Mayo Clinic. “RSL has the potential to be adapted to most lesions amenable to a percutaneous (under the skin) approach.”

This advance in technology can be applied to a wide variety of cancers. For example, metastatic melanoma deposits scattered throughout the body can be identified by imaging studies and seeds implanted via CT-guided or ultrasound-guided techniques. Surgeons can then precisely locate these tumor deposits and remove them without significantly disturbing nearby vital structures.

Radioactive seed localization is also a flexible technology. It can be completed at the same time that other imaging studies are done. Surgeons then have up to five days to identify these seeds and excise the tumor. The radiation dose from the seeds is so negligible that surgeons removing the tumor need no extra protective covering.

The early results of the study demonstrate complete destruction of the metastasized tissues with no mortality and only two minor postsurgical infections. The scheduling of the placement of the seed need not be done on the same day as the PET and/or CT scans are performed, thereby maximizing convenience to the patient without sacrificing clinical outcome.

Radioactive seed localization offers the potential to change the way complex tumors are treated, owing to its safety, convenience to the patient, relatively low dose of radiation administered and success in excising the entire affected tissue.

For more information: www.SurgRad.com.

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve